Phibro Animal Health | PAHC - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Phibro Animal Health

Phibro Animal Health reported $481.44M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
ANI Pharmaceuticals ANIP:US USD 286.31M 212K
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Depomed DEPO:US USD 38.62M 28.25M
Eli Lilly LLY:US USD 18.88B 2.64B
Endo International ENDP:US USD 7.69B 7.69B
Henry Schein HSIC:US USD 1.31B 163M
Idexx Laboratories IDXX:US USD 1.2B 145.52M
Knight Therapeutics Inc GUD:CN CAD 82.64M 4.94M
Pacira PCRX:US USD 553.77M 135.7M
Patterson Companies PDCO:US USD 662.91M 388K
Phibro Animal Health PAHC:US USD 481.44M 5.21M
Prestige Brands PBH:US USD 1.35B 79M
Supernus Pharmaceuticals SUPN:US USD 480.86M 78.9M
Zoetis ZTS:US USD 6.56B 1.34B